KAMIL ALI-JACKSON, ESQ.

Corporate Board Profile

Tech Score: 0/100

RIGEL PHARMACEUTICALS INC

Filing Date	Source Excerpt
2023-04-14	Kamil Ali-Jackson, Esq., age 64, joined us as a director in December 2021. ... Ms. Ali-Jackson currently serves on the board of directors, audit committee, compensation committee, and is the chair of the nominating and corporate governance committee of PDS Biotechnology Corporation, a publicly traded clinical stage biopharmaceutical company, as an independent director of Moda Operandi, a privately held online luxury retail company, and as an advisor to life sciences companies and nonprofit organizations. ... Ms. Ali-Jackson was selected to serve as a member of the Board in part due to her broad experience in the areas of acquisitions, licensing, legal, compliance and corporate governance as well as her experience as an executive officer, legal counsel, and co-founder in the life sciences industry. ... The following directors are currently members of the Audit Committee: Ms. Ali-Jackson ... The following directors are currently members of the Compensation Committee: Ms. Ali-Jackson ... The following directors are currently members of the Corporate Governance, Health Care Compliance Oversight and Nominating Committee: Ms. Ali-Jackson (Chair). ... The following table shows the compensation of all non-employee directors of the Company for the fiscal year ended December 31, 2022: Kamil Ali-Jackson, Esq. Fees Earned or Paid in Cash ($) 67,238 Stock Awards ($) 37,688 Option Awards ($) 30,695 Total ($) 135,621.

Filing Date

Source Excerpt

2023-04-14

Kamil Ali-Jackson, Esq., age 64, joined us as a director in December 2021. ... Ms. Ali-Jackson currently serves on the board of directors, audit committee, compensation committee, and is the chair of the nominating and corporate governance committee of PDS Biotechnology Corporation, a publicly traded clinical stage biopharmaceutical company, as an independent director of Moda Operandi, a privately held online luxury retail company, and as an advisor to life sciences companies and nonprofit organizations. ... Ms. Ali-Jackson was selected to serve as a member of the Board in part due to her broad experience in the areas of acquisitions, licensing, legal, compliance and corporate governance as well as her experience as an executive officer, legal counsel, and co-founder in the life sciences industry. ... The following directors are currently members of the Audit Committee: Ms. Ali-Jackson ... The following directors are currently members of the Compensation Committee: Ms. Ali-Jackson ... The following directors are currently members of the Corporate Governance, Health Care Compliance Oversight and Nominating Committee: Ms. Ali-Jackson (Chair). ... The following table shows the compensation of all non-employee directors of the Company for the fiscal year ended December 31, 2022: Kamil Ali-Jackson, Esq. Fees Earned or Paid in Cash ($) 67,238 Stock Awards ($) 37,688 Option Awards ($) 30,695 Total ($) 135,621.

Data sourced from SEC filings. Last updated: 2026-03-05